<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Joint aspiration or injection in children: Indications, technique, and complications</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Joint aspiration or injection in children: Indications, technique, and complications</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Joint aspiration or injection in children: Indications, technique, and complications</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Deirdre De Ranieri, MD, RhMSUS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Suzanne C Li, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Siobhan M Case, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Joint aspiration (arthrocentesis) and glucocorticoid injections are used for diagnostic and therapeutic purposes in the care of children with arthritis.</p><p>The indications, techniques, and complications of intraarticular aspiration and injection in children are reviewed here. Details regarding ultrasound guidance, the medications used, and the benefits of this procedure for specific conditions are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14926.html" rel="external">"Musculoskeletal ultrasonography: Guided injection and aspiration of joints and related structures"</a> and  <a class="medical medical_review" href="/z/d/html/6415.html" rel="external">"Oligoarticular juvenile idiopathic arthritis", section on 'Initial therapy'</a> and  <a class="medical medical_review" href="/z/d/html/6428.html" rel="external">"Polyarticular juvenile idiopathic arthritis: Treatment", section on 'Intraarticular glucocorticoids'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>Joint aspiration is primarily performed for diagnostic purposes, usually to rule out infection in a swollen joint. Aspirating fluid can also be therapeutic, as it decompresses the joint, thus relieving pressure and pain in children who have significant swelling. Therapeutic joint injection involves the administration of glucocorticoids to suppress joint inflammation. In pediatric patients who present for the first time with a swollen joint, aspiration of the synovial fluid is recommended even if the patient does not appear to have a septic joint. Synovial fluid assessment guides diagnosis and management.</p><p class="headingAnchor" id="H3"><span class="h2">Diagnostic indications</span><span class="headingEndMark"> — </span>In children with arthritis, joint aspiration is most often performed to differentiate bacterial (septic) arthritis from other inflammatory conditions. Arthrocentesis is of limited diagnostic value in children whose joint inflammation is not thought to be infectious in origin. Thus, other causes of arthritis should be investigated if the synovial fluid is not suggestive of an infectious etiology, unless grossly bloody fluid is found.</p><p>Certain characteristics of synovial fluid, such as color, clarity, and viscosity, can give the clinician clues about the etiology of the effusion. Laboratory findings are also helpful in differentiating the different types of synovial fluid (see  <a class="medical medical_review" href="/z/d/html/1828.html" rel="external">"Synovial fluid analysis"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Normal synovial fluid is clear or pale yellow, viscous, and usually has less than 200 white blood cells (WBC)/mm<sup>3</sup> with &lt;25 percent polymorphonuclear neutrophils (PMNs).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In inflammatory arthritis, the fluid is usually yellow and viscous, and the WBC count can range from 2000/mm<sup>3</sup> to as high as 75,000/mm<sup>3</sup> and typically has a neutrophilic predominance.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Grossly bloody fluid suggests either a bleeding diathesis or tenosynovial giant cell tumor (TGCT), which was formerly known as pigmented villonodular synovitis (PVNS).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Synovial fluid from a septic joint is usually opaque (may be green), of variable viscosity, and can have upwards of 300,000 WBC/mm<sup>3</sup>, at least 75 percent of which are PMNs. Synovial fluid glucose levels decrease in the setting of infection and are usually &lt;50 percent of serum glucose [<a href="#rid1">1</a>].</p><p></p><p>However, a lower synovial fluid WBC count does not reliably rule out septic arthritis, and Gram stain is positive in less than 50 percent of samples from infected joints [<a href="#rid2">2</a>]. Thus, empiric antibiotic therapy is administered promptly after aspiration in all patients with signs and symptoms suggestive of septic arthritis and is continued until culture results are available. Severe joint damage can occur if a septic joint is not treated within days [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/6030.html" rel="external">"Bacterial arthritis: Clinical features and diagnosis in infants and children"</a> and  <a class="medical medical_review" href="/z/d/html/6033.html" rel="external">"Bacterial arthritis: Treatment and outcome in infants and children", section on 'Empiric parenteral therapy'</a>.)</p><p>The different subtypes of juvenile idiopathic arthritis (JIA) are not reliably distinguished from each other based upon synovial fluid analysis. They are diagnosed based upon clinical parameters, laboratory profile, and family history. However, children with documented JIA may subsequently develop infection in a concurrently arthritic joint and thereby require joint aspiration to differentiate between the two. Other conditions in the differential diagnosis of noninflammatory arthritis include orthopedic injuries, leukemic synovitis, and neurologic conditions such as Charcot arthropathy. Gout and other crystal-induced inflammatory conditions, in which arthrocentesis is often diagnostic, are rare in children and adolescents. (See  <a class="medical medical_review" href="/z/d/html/6415.html" rel="external">"Oligoarticular juvenile idiopathic arthritis", section on 'Differential diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/6405.html" rel="external">"Evaluation of the child with joint pain and/or swelling", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Therapeutic indications</span><span class="headingEndMark"> — </span>Therapeutic indications include aspiration of painful fluid collections and injection of glucocorticoids [<a href="#rid4">4,5</a>].</p><p class="headingAnchor" id="H5"><span class="h3">Joint aspiration</span><span class="headingEndMark"> — </span>Joint aspiration may be both diagnostic and therapeutic in patients who have large effusions. The nociceptors that innervate the joint capsule are stimulated by pressure, so decompression of the joint via aspiration helps to relieve this pain [<a href="#rid6">6</a>]. However, fluid is likely to rapidly reaccumulate if appropriate therapy is not given. For patients with septic arthritis, surgical drainage via either open arthrotomy or serial aspirations remain the procedures of choice for fluid removal in children [<a href="#rid7">7</a>], particularly if the aspirated synovial fluid is purulent [<a href="#rid8">8,9</a>]. (See  <a class="medical medical_review" href="/z/d/html/6033.html" rel="external">"Bacterial arthritis: Treatment and outcome in infants and children"</a>.)</p><p class="headingAnchor" id="H6"><span class="h3">Joint injections</span><span class="headingEndMark"> — </span>Intraarticular glucocorticoid injections are often used to treat inflammatory arthritis [<a href="#rid4">4,5,10-12</a>]. They are most commonly used as initial management (in conjunction with nonsteroidal antiinflammatory drugs [NSAIDs]) in children with oligoarticular JIA. However, they are also effective in polyarticular JIA to expeditiously control disease flares while initiating or adjusting systemic medications. Antibiotics are not administered intraarticularly in children with septic arthritis, since intravenous antibiotics reach sufficient concentrations in the synovial fluid. Furthermore, introducing antimicrobials directly into the joint may cause an increased inflammatory response [<a href="#rid13">13</a>]. The use of intraarticular glucocorticoids as adjunctive therapy in children with oligoarticular and polyarticular JIA is discussed in greater detail separately. Specific agents and dosing are discussed below. (See  <a class="medical medical_review" href="/z/d/html/6415.html" rel="external">"Oligoarticular juvenile idiopathic arthritis", section on 'Initial therapy'</a> and  <a class="medical medical_review" href="/z/d/html/6428.html" rel="external">"Polyarticular juvenile idiopathic arthritis: Treatment", section on 'Intraarticular glucocorticoids'</a> and <a class="local">'Drugs and dosing for joint injection'</a> below.)</p><p class="headingAnchor" id="H7"><span class="h1">CONTRAINDICATIONS</span><span class="headingEndMark"> — </span>Contraindications to arthrocentesis or intraarticular injection of a noninfected joint include:</p><p class="bulletIndent1"><span class="glyph">●</span>Infection of the overlying skin or soft tissue</p><p class="bulletIndent1"><span class="glyph">●</span>Bacteremia [<a href="#rid14">14</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Allergy to any of the medications being considered for injection</p><p></p><p>Patients should be screened for bleeding risk by taking a thorough clinical history (family, surgical, dental, obstetric, traumatic injury, medications), with tests of clotting function performed if an increased risk of bleeding is identified [<a href="#rid15">15</a>]. There does not seem to be an increased risk of bleeding complications in patients on anticoagulation who undergo joint aspiration or injection [<a href="#rid16">16,17</a>]. In patients with hemophilia, preprocedural factor VIII (FVIII) is recommended followed by postprocedural rest [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H8"><span class="h1">TECHNIQUE</span><span class="headingEndMark"> — </span>Both arthrocentesis and intraarticular glucocorticoid injections should be performed by experienced practitioners following an explanation of the process as well as the indications, risks, and benefits of the procedure.</p><p class="headingAnchor" id="H9"><span class="h2">Anesthesia</span><span class="headingEndMark"> — </span>There is no standardized method for delivering anesthesia to children undergoing joint injections [<a href="#rid19">19</a>]. Many children will tolerate arthrocentesis in the office setting with the aid of topical or injected local anesthesia and appropriate reassurance. Procedural anxiolysis, moderate or deep sedation, and general anesthesia are anesthesia options for children who have significant anxiety about procedures, children who are uncooperative, children receiving multiple joint injections, and children with a prior negative experience [<a href="#rid20">20-22</a>]. A minimal anxiolysis/sedation (MAS) protocol is an alternative to general anesthesia in patients undergoing intraarticular glucocorticoid injections into larger joints such as the knee. This protocol uses Child Life services, a topical numbing medication, and <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">nitrous oxide</a> and intranasal <a class="drug drug_pediatric" data-topicid="13298" href="/z/d/drug information/13298.html" rel="external">fentanyl</a> administered by a sedation service. One study noted a 33 percent reduction in operating expenses when intraarticular injections were performed in this manner versus in the operating room [<a href="#rid22">22</a>]. The various types of anesthesia are reviewed in greater detail separately. Specifics related to joint injection and aspiration are reviewed below. (See  <a class="medical medical_review" href="/z/d/html/6338.html" rel="external">"Clinical use of topical anesthetics in children"</a> and  <a class="medical medical_review" href="/z/d/html/6324.html" rel="external">"Subcutaneous infiltration of local anesthetics"</a> and  <a class="medical medical_review" href="/z/d/html/6330.html" rel="external">"Procedural sedation in children: Approach"</a>.)</p><p><a class="drug drug_pediatric" data-topicid="12551" href="/z/d/drug information/12551.html" rel="external">Lidocaine</a> 1% without <a class="drug drug_pediatric" data-topicid="13272" href="/z/d/drug information/13272.html" rel="external">epinephrine</a> is the most commonly used local anesthetic given its rapid onset of action. It is used topically or subcutaneously to locally anesthetize the skin at the site of needle entry as well as subcutaneously in the tissue along the anticipated track of the needle. Many clinicians also use "buffered lidocaine," which is lidocaine that is buffered with <a class="drug drug_pediatric" data-topicid="12795" href="/z/d/drug information/12795.html" rel="external">sodium bicarbonate</a> to reduce the pH of the preparation and thus reduces the burning sensation of the lidocaine [<a href="#rid23">23</a>]. Lidocaine can also be delivered using a needle-free jet injection system (known as a "J-tip"), which is helpful for those children who have significant needle phobia [<a href="#rid24">24</a>]. This delivery system is not painful, but it is loud and can startle patients, so they should be forewarned. Local anesthetics should <strong>not</strong> be mixed with the glucocorticoid preparation, as these agents (lidocaine, <a class="drug drug_pediatric" data-topicid="13100" href="/z/d/drug information/13100.html" rel="external">bupivacaine</a>, etc) are chondrotoxic. (See <a class="local">'Drugs and dosing for joint injection'</a> below.)</p><p>Iontophoresis is another method of delivering anesthesia. It uses electric currents rather than carbon dioxide to drive <a class="drug drug_pediatric" data-topicid="12551" href="/z/d/drug information/12551.html" rel="external">lidocaine</a> into the skin and has a more limited application because it can cause burns, is painful, and has a slower onset of action and shallower penetration than the jet injection system [<a href="#rid19">19</a>].</p><p><a class="drug drug_general" data-topicid="8930" href="/z/d/drug information/8930.html" rel="external">Ethyl chloride</a> spray is also commonly used to "freeze" the area of intended needle insertion prior to injection [<a href="#rid25">25</a>]. Eutectic mixture of local anesthetics (EMLA) cream (a combination of topical <a class="drug drug_pediatric" data-topicid="12551" href="/z/d/drug information/12551.html" rel="external">lidocaine</a> 2.5% and <a class="drug drug_general" data-topicid="10228" href="/z/d/drug information/10228.html" rel="external">prilocaine</a> 2.5%) can be applied topically 30 to 60 minutes before a procedure to decrease the pain of the needle stick. In a randomized trial of 31 children, EMLA was found to be no more effective than placebo for preventing injection site pain [<a href="#rid26">26</a>]. However, despite this finding, some feel that the placebo effect is helpful [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H12"><span class="h2">Needle and syringe size</span><span class="headingEndMark"> — </span>The needle and syringe used should be appropriate to the size of the joint and degree of effusion [<a href="#rid28">28</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A 22-gauge 1.5 inch needle is recommended for arthrocentesis of most joints, such as the knee, ankle, hip, elbow, or shoulder, due to the viscosity of the synovial fluid. A larger-bore needle, either 18 or 20 gauge, is often used to drain large knee effusions or Baker's cysts as the fluid can be quite gelatinous and difficult to aspirate. Longer needles, such as spinal needles (either 2.5 or 3.5 inch), are often necessary to access the deeper joints, such as the hip or shoulder. Smaller joints such as wrists, fingers, and toes are more appropriately accessed with a smaller 25-gauge or 27-gauge needle (1.25 inch or shorter, depending upon the joint).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Syringe size is dependent upon the amount of fluid the clinician intends to remove. Only a small amount (approximately 5 mL) is necessary for diagnostic purposes. A larger syringe (20 to 50 mL) is useful if a greater amount of fluid is to be removed.</p><p></p><p class="headingAnchor" id="H15"><span class="h2">Sterile preparation</span><span class="headingEndMark"> — </span>Appropriate aseptic technique should be used when performing joint aspiration/injection. The area should be sterilized with either povidone-iodine or <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">chlorhexidine</a>. A sterile drape may be used, and sterile gloves are recommended. If ultrasound guidance is used, a sterile probe cover is also recommended if the needle may come in contact with the gel [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/z/d/html/13989.html" rel="external">"Infection control in the outpatient setting", section on 'Safe injection practices'</a> and  <a class="medical medical_review" href="/z/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection", section on 'Standard precautions'</a>.)</p><p class="headingAnchor" id="H16"><span class="h2">Anatomic approaches</span><span class="headingEndMark"> — </span>The provider performing the procedure should have a thorough knowledge of the anatomy of the joint [<a href="#rid30">30-33</a>] and should choose the shortest path possible to the target while taking care to avoid nerves, blood vessels, and tendons [<a href="#rid34">34</a>]. The preferred anatomic approaches for the following joints are shown in the accompanying figures  (<a class="graphic graphic_figure graphicRef72665 graphicRef103524 graphicRef52630 graphicRef63588 graphicRef53804 graphicRef81500 graphicRef51897" href="/z/d/graphic/72665.html" rel="external">figure 1A-G</a>).</p><p class="headingAnchor" id="H416232811"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>Ultrasonography is the most commonly used imaging modality to assist with accurate needle placement for aspiration/injection [<a href="#rid35">35,36</a>]. Aspiration/injection of the temporomandibular [<a href="#rid37">37</a>], hip, shoulder, and ankle joints is often performed with computed tomography (CT) or fluoroscopic guidance, but ultrasound guidance (if available) obviates the need for CT or fluoroscopy and reduces radiation exposure for these patients. Ultrasonography is also helpful when injecting the ankle and wrist joints as there are several joint spaces in each that do not always communicate, often necessitating multiple injections. Tenosynovial effusions are also easily accessed using ultrasound. The ready availability of ultrasonography has made it the technique of choice for these procedures. However, it is important to have a competent ultrasonographer for the procedure. (See  <a class="medical medical_review" href="/z/d/html/6428.html" rel="external">"Polyarticular juvenile idiopathic arthritis: Treatment", section on 'Intraarticular glucocorticoids'</a>.)</p><p class="headingAnchor" id="H416232881"><span class="h2">Synovial fluid collection</span><span class="headingEndMark"> — </span>Synovial fluid should be collected in a heparinized syringe so that clot formation does not preclude enumeration of leukocytes. Collection and analysis of synovial fluid are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/1828.html" rel="external">"Synovial fluid analysis"</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Injection</span><span class="headingEndMark"> — </span>The clinician should always aspirate the joint before injecting glucocorticoids into it to confirm that the needle is in the joint space [<a href="#rid38">38</a>]. There are limited data in children regarding this topic, but, in adults with rheumatoid arthritis, complete aspiration of the synovial fluid prior to the injection of glucocorticoid leads to more sustained remission [<a href="#rid39">39</a>]. Aspirated synovial fluid should be straw colored, not bloody or purulent. If it is either of the latter, glucocorticoids should not be injected until further work-up is done, since the swelling may be due to infection, hemarthrosis, or a tenosynovial giant cell tumor (TGCT). After aspiration, the syringe containing the aspirated fluid should be removed, and the syringe containing the glucocorticoid should be attached. To facilitate the exchange of syringes, a sterile hemostat may be used to hold and stabilize the needle within the joint space while changing syringes. Alternatively, a "reciprocating syringe" enables one to aspirate and inject a joint using the same needle without having to exchange syringes [<a href="#rid40">40</a>]. This approach results in decreased procedure time and less procedural pain. However, these syringes are more expensive than regular syringes, are cumbersome to hold, and are not readily available in most clinics [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H416232907"><span class="h2">Additional precautions</span><span class="headingEndMark"> — </span>Clinicians performing joint aspiration in a child with a joint effusion and pain should not only evaluate the joint but also the surrounding bones. Children with early osteomyelitis may develop a sterile sympathetic effusion (which appears benign) in the adjacent joint. Sympathetic effusions may also occur in children with leukemia or other neoplastic conditions. Failure to recognize these conditions in a timely fashion may lead to a worse prognosis. (See  <a class="medical medical_review" href="/z/d/html/6064.html" rel="external">"Hematogenous osteomyelitis in children: Clinical features and complications", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/z/d/html/6243.html" rel="external">"Overview of common presenting signs and symptoms of childhood cancer", section on 'Bone and joint pain'</a>.)</p><p class="headingAnchor" id="H1198427605"><span class="h1">DRUGS AND DOSING FOR JOINT INJECTION</span><span class="headingEndMark"> — </span>Historically, <a class="drug drug_pediatric" data-topicid="12858" href="/z/d/drug information/12858.html" rel="external">triamcinolone</a> hexacetonide was the glucocorticoid of choice for intraarticular injections in patients with juvenile idiopathic arthritis (JIA) due to its long duration of action compared with other glucocorticoid preparations, such as the commonly used triamcinolone acetonide [<a href="#rid42">42-46</a>], and milder side effects. Compared with triamcinolone acetonide, triamcinolone hexacetonide is a larger molecule with lower solubility. Thus, it is released more slowly into the joint, presumably contributing to its longer duration of action. Triamcinolone hexacetonide is also released into the systemic circulation more slowly, which is probably the reason that less systemic toxicity is seen with triamcinolone hexacetonide [<a href="#rid47">47</a>]. Specifically, one sees less adrenal suppression with triamcinolone hexacetonide compared with triamcinolone acetonide. Triamcinolone hexacetonide has not been commercially available in the United States for over a decade; however, other medications with the same chemical formulation have been imported from Europe under the US Food and Drug Administration (FDA) Personal Importation Program (PIP). US FDA approval is pending. However, most providers use triamcinolone acetonide, which is readily available. Another alternative is <a class="drug drug_pediatric" data-topicid="12601" href="/z/d/drug information/12601.html" rel="external">methylprednisolone</a> acetate.</p><p>There are no established dosing guidelines for intraarticular glucocorticoid injections in JIA. Doses of these medications often vary according to age and weight of the child, size of the vial, and the provider's experience [<a href="#rid44">44</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>In general, <a class="drug drug_pediatric" data-topicid="12858" href="/z/d/drug information/12858.html" rel="external">triamcinolone</a> acetonide is the most commonly used intraarticular glucocorticoid. Historically, 1 mg/kg of triamcinolone acetonide to a maximum of 40 mg was used in large joints (such as knees, shoulders, hips), up to 20 mg in medium-sized joints (such as ankles, wrists and elbows), and between 5 to 10 mg in small joints (fingers, toes). More recent data suggest that increasing the dose of triamcinolone acetonide is associated with better outcomes in terms of duration of remission. In two studies, for example, triamcinolone acetonide dosing up to 2 mg/kg (or 80 mg) for large joints and up to 60 mg for medium joints led to longer-lasting remission [<a href="#rid43">43,44</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="12858" href="/z/d/drug information/12858.html" rel="external">Triamcinolone</a> hexacetonide doses vary according to joint: 1 mg/kg up to 40 mg for knees, 0.75 mg/kg up to 30 mg for ankles and elbows, 0.5 mg/kg up to 20 mg for wrists, and 5 to 10 mg for the small joints of the hands and foot [<a href="#rid43">43,48</a>]. The maximum dosing per joint of triamcinolone hexacetonide is often used regardless of the age or weight of the patient.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="12601" href="/z/d/drug information/12601.html" rel="external">Methylprednisolone</a> acetate is another glucocorticoid preparation that is occasionally used in smaller or more difficult to access joints. It is more concentrated, enabling more medication to be administered into the joint. It is generally used at doses of 5 to 10 mg for small joints and 20 to 40 mg in the subtalar and intertarsal joints [<a href="#rid46">46,48</a>]. It is more soluble, and some data suggest there is less subcutaneous atrophy compared with the other glucocorticoid formulations (<a class="drug drug_pediatric" data-topicid="12858" href="/z/d/drug information/12858.html" rel="external">triamcinolone</a> acetonide and triamcinolone hexacetonide).</p><p></p><p>There are also no established guidelines about the number of glucocorticoid joint injections patients with JIA can receive. However, in general, three joint injections per joint per year is considered the limit [<a href="#rid49">49</a>].</p><p>In the past, it was customary to mix local anesthetics (usually <a class="drug drug_pediatric" data-topicid="12551" href="/z/d/drug information/12551.html" rel="external">lidocaine</a>) with the glucocorticoid preparation to provide temporary pain relief for an intraarticular injection. However, data have since shown the chondrotoxic effect that local anesthetics can have in a joint [<a href="#rid50">50,51</a>]. This chondrotoxic effect was seen with lidocaine even at low doses and was greater when local anesthetics were combined with glucocorticoids. Thus, lidocaine or other anesthetics are not used for intraarticular injection. A small volume of sterile <a class="drug drug_pediatric" data-topicid="12796" href="/z/d/drug information/12796.html" rel="external">saline</a> may be used to flush the needle before withdrawing it from the joint to help prevent extravasation of the glucocorticoid, which can lead to skin atrophy and dyspigmentation (excluding fingers and toes where the joint space is too small to accommodate any additional fluid).</p><p>Biologics such as tumor necrosis factor (TNF) inhibitors have been used selectively as intraarticular therapy in patients with JIA. This practice is not common, however, and has been mainly reserved for temporomandibular joint (TMJ) synovitis who have failed both intraarticular glucocorticoids as well as systemic TNF therapy. There are small studies and case reports that have investigated the response of different joints to varying doses of intraarticular TNF inhibitors (including <a class="drug drug_pediatric" data-topicid="13077" href="/z/d/drug information/13077.html" rel="external">adalimumab</a>, <a class="drug drug_pediatric" data-topicid="13284" href="/z/d/drug information/13284.html" rel="external">etanercept</a>, and <a class="drug drug_pediatric" data-topicid="13381" href="/z/d/drug information/13381.html" rel="external">infliximab</a>) with mixed results [<a href="#rid52">52</a>]. Some studies have shown limited benefit [<a href="#rid53">53,54</a>], whereas other results appear more promising [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H20"><span class="h1">POSTINJECTION CARE</span><span class="headingEndMark"> — </span>In the past, patients were advised to refrain from excessive activity for 24 to 48 hours after intraarticular glucocorticoid injections. However, the data on this recommendation stem from studies on knee arthritis in adults. There is very little pediatric literature on this topic, but what is available suggests that certain joints, such as the wrists and elbows, do not have better outcomes after joint immobilization [<a href="#rid56">56,57</a>]. In addition, there is no evidence to support the common recommendation to not bathe or shower for 24 hours after a glucocorticoid injection.</p><p class="headingAnchor" id="H21"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Complications due to joint aspiration or injections in children are infrequent and rarely serious [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H22"><span class="h2">Postinjection inflammatory reaction</span><span class="headingEndMark"> — </span>An inflammatory reaction thought to be secondary to irritation of the synovium by microcrystals of glucocorticoids can follow intraarticular glucocorticoid injections [<a href="#rid59">59</a>]. This inflammatory reaction rarely occurs in children [<a href="#rid60">60-62</a>]. Postinjection inflammatory reactions occur soon after the injection and resolve spontaneously within two days and are treated conservatively with local application of ice and appropriate analgesics. Repeat aspiration to exclude iatrogenic infection is necessary if the joint is red, hot, or painful or the patient develops a fever. In general, infection is more likely if joint pain, swelling, and redness last longer than 48 hours or these symptoms begin more than 48 hours postinjection.</p><p class="headingAnchor" id="H23"><span class="h2">Subcutaneous atrophy and depigmentation</span><span class="headingEndMark"> — </span>Subcutaneous atrophy and depigmentation may occur if there has been leakage of the glucocorticoid into the soft tissues at the time of intraarticular glucocorticoid injection [<a href="#rid63">63</a>]. The reported incidence of this complication varies from 1 to 8 percent of intraarticular glucocorticoid injections [<a href="#rid62">62,64,65</a>]. These changes usually resolve over the course of one to two years.</p><p class="headingAnchor" id="H24"><span class="h2">Intraarticular calcifications</span><span class="headingEndMark"> — </span>Calcifications are often incidental findings on imaging following intraarticular glucocorticoid injection [<a href="#rid66">66-68</a>] and are usually located periarticularly or in the joint capsule. Almost all patients are asymptomatic [<a href="#rid62">62,66,67</a>]. The pathogenesis of these calcifications is unclear.</p><p class="headingAnchor" id="H25"><span class="h2">Infection</span><span class="headingEndMark"> — </span>Iatrogenic septic joint after intraarticular glucocorticoid injection is rare. There are little data in children, but, in adult patients who have received joint injections, the rate of iatrogenic infection is between 0.002 and 0.07 percent [<a href="#rid69">69</a>]. Preventive steps to avoid this complication include use of aseptic technique and avoiding injection if there is bacteremia or overlying tissue infection. (See <a class="local">'Sterile preparation'</a> above and <a class="local">'Contraindications'</a> above.)</p><p class="headingAnchor" id="H26"><span class="h2">Hemorrhage</span><span class="headingEndMark"> — </span>As with any invasive procedure, the possibility of bleeding exists. Hemarthrosis following injection is rare. Aspiration of a large amount of blood at the time of the procedure suggests the possibilities of trauma, a bleeding disorder (eg, hemophilia), vascular malformation, or a tenosynovial giant cell tumor (TGCT). Of note, arthrocentesis and joint injections appear to be safe and well tolerated in those receiving anticoagulation [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/z/d/html/5605.html" rel="external">"Overview of hemarthrosis"</a>.)</p><p>There is a low risk of hemorrhage in patients with significant thrombocytopenia. The patient can be given a platelet transfusion if there is an urgent reason for doing the aspiration in the face of a critically low platelet count. In this setting, consultation with a pediatric hematologist is useful.</p><p class="headingAnchor" id="H27"><span class="h2">Effects on growing articular cartilage</span><span class="headingEndMark"> — </span>The limited available data suggest that there is no long-term negative effect of glucocorticoids upon articular cartilage in childhood.</p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 14 children with chronic arthritis, magnetic resonance imaging was performed before and seven weeks and 13 months after glucocorticoid injection [<a href="#rid70">70</a>]. There was no evidence of cartilage deterioration and no effect upon skeletal growth.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a second study, 30 children were followed with plain radiographs after intraarticular glucocorticoid injections for chronic arthritis. No evidence of cartilage damage was found [<a href="#rid71">71</a>].</p><p></p><p class="headingAnchor" id="H29"><span class="h1">SYSTEMIC EFFECTS OF INTRAARTICULAR GLUCOCORTICOIDS</span><span class="headingEndMark"> — </span>Following the injection of intraarticular glucocorticoids, patients often note improvement in joints that were not injected, consistent with the notion that there is also some systemic absorption of the injected glucocorticoid [<a href="#rid10">10,11</a>]. Studies in both children and adults have noted transient suppression of endogenous cortisol following injection [<a href="#rid72">72,73</a>]. Cushing syndrome has been reported in juvenile idiopathic arthritis (JIA) patients receiving intraarticular glucocorticoid injections with either <a class="drug drug_pediatric" data-topicid="12858" href="/z/d/drug information/12858.html" rel="external">triamcinolone</a> acetonide or triamcinolone hexacetonide [<a href="#rid46">46,74</a>]. Patients with type 1 diabetes often experience fluctuations in their blood sugar levels for days, necessitating more frequent insulin adjustments. Leukocytosis has been reported, with a neutrophilic predominance after intraarticular glucocorticoid therapy. Facial and body flushing, emotional lability, menstrual irregularity, sleep disturbance, increased appetite, weight gain, and acne are also commonly reported after intraarticular glucocorticoid injections [<a href="#rid75">75,76</a>]. Systemic side effects, particularly adrenal suppression, are more common after intraarticular injection with triamcinolone acetonide or <a class="drug drug_pediatric" data-topicid="13046" href="/z/d/drug information/13046.html" rel="external">betamethasone</a> compared with triamcinolone hexacetonide [<a href="#rid74">74</a>] because triamcinolone acetonide has a higher solubility and resultant peak plasma levels than triamcinolone hexacetonide [<a href="#rid77">77,78</a>]. There is a direct relationship between peak plasma glucocorticoid levels and endogenous <a class="drug drug_pediatric" data-topicid="13361" href="/z/d/drug information/13361.html" rel="external">hydrocortisone</a> suppression [<a href="#rid47">47</a>]. (See <a class="local">'Joint injections'</a> above.)</p><p class="headingAnchor" id="H30"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic and therapeutic indications</strong> – Joint aspiration and injections are used for diagnostic and therapeutic purposes in the care of children with arthritis. In pediatric patients, synovial fluid aspiration is used primarily to evaluate for infection, but it can also provide relief in children with large effusions through decompression of the joint space. Intraarticular glucocorticoid injections are used to treat inflammatory arthritis. It is important to rule out infection prior to injecting glucocorticoids into a joint. (See <a class="local">'Introduction'</a> above and <a class="local">'Diagnostic indications'</a> above and <a class="local">'Therapeutic indications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anesthesia</strong> – Many children will tolerate arthrocentesis in the office setting with the aid of local anesthesia and appropriate reassurance. However, procedural sedation or general anesthesia should be used in children who are uncooperative, have significant anxiety about the procedure, or are undergoing multiple joint injections. (See <a class="local">'Anesthesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Selection of needle and syringe size</strong> – Needle and syringe size should be chosen based upon both the size of the joint and the size of the effusion. Larger-bore needles are necessary when aspirating fluid due to the viscosity of synovial fluid. Smaller-bore needles are necessary when injecting superficial joints, such as wrists and fingers, to minimize the incidence of skin atrophy and depigmentation that may result from extravasation of glucocorticoid from the joint. (See <a class="local">'Needle and syringe size'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sterile preparation</strong> – The implementation of sterile technique during aspiration/injection is essential to prevent iatrogenic infection. (See <a class="local">'Sterile preparation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anatomic approaches and use of ultrasound guidance</strong> – A complete understanding of the joint and surrounding nerves and vessels is important when performing palpation-guided joint aspiration and/or injection. The site of aspiration and/or injection should take into account the shortest and safest route possible, minimizing tissue injury and avoiding nerves and vessels. Ultrasound-guided aspirations and injections are becoming more common and enable providers to visualize their trajectory and avoid important structures. However, they should only be performed by providers competent in the use of musculoskeletal ultrasound. (See <a class="local">'Anatomic approaches'</a> above and <a class="local">'Imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – In children, complications due to joint aspiration or injections are infrequent and rarely serious. Patient education before and after the procedure should include discussion of the risks, including infection, skin depigmentation, soft tissue atrophy, crystal reactions, as well as more common side effects of intraarticular glucocorticoids, such as flushing, menstrual irregularities, and emotional lability. (See <a class="local">'Complications'</a> above and <a class="local">'Systemic effects of intraarticular glucocorticoids'</a> above.)</p><p></p><p class="headingAnchor" id="H2511100070"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Thomas JA Lehman, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Faryna A, Goldenberg K. Joint fluid. In: Clinical Methods: The History, Physical, and Laboratory Examinations, 3rd ed, Walker HK, Hall WD, Hurst JW (Eds), Butterworths, Boston 1990.</li><li><a class="nounderline abstract_t">Bram JT, Baldwin KD, Blumberg TJ. Gram Stain is Not Clinically Relevant in Treatment of Pediatric Septic Arthritis. J Pediatr Orthop 2018; 38:e536.</a></li><li><a class="nounderline abstract_t">Ross JJ. Septic Arthritis of Native Joints. Infect Dis Clin North Am 2017; 31:203.</a></li><li><a class="nounderline abstract_t">Jennings H, Hennessy K, Hendry GJ. The clinical effectiveness of intra-articular corticosteroids for arthritis of the lower limb in juvenile idiopathic arthritis: a systematic review. Pediatr Rheumatol Online J 2014; 12:23.</a></li><li><a class="nounderline abstract_t">Papadopoulou C, Kostik M, Gonzalez-Fernandez MI, et al. Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era. Arthritis Care Res (Hoboken) 2013; 65:1112.</a></li><li><a class="nounderline abstract_t">McDougall JJ. Arthritis and pain. Neurogenic origin of joint pain. Arthritis Res Ther 2006; 8:220.</a></li><li><a class="nounderline abstract_t">Gill P, Sanders JE. Emergency department management of pediatric septic arthritis and osteomyelitis. Pediatr Emerg Med Pract 2019; 16:1.</a></li><li><a class="nounderline abstract_t">Givon U, Liberman B, Schindler A, et al. Treatment of septic arthritis of the hip joint by repeated ultrasound-guided aspirations. J Pediatr Orthop 2004; 24:266.</a></li><li><a class="nounderline abstract_t">Shetty AK, Gedalia A. Management of septic arthritis. Indian J Pediatr 2004; 71:819.</a></li><li><a class="nounderline abstract_t">FREYBERG RH, PATTERSON M, ADAMS CH, et al. Practical considerations of the use of cortisone and ACTH in rheumatoid arthritis. Ann Rheum Dis 1951; 10:1.</a></li><li><a class="nounderline abstract_t">HOLLANDER JL, BROWN EM Jr, JESSAR RA, BROWN CY. Hydrocortisone and cortisone injected into arthritic joints; comparative effects of and use of hydrocortisone as a local antiarthritic agent. J Am Med Assoc 1951; 147:1629.</a></li><li><a class="nounderline abstract_t">de Oliveira Fonseca-Machado M, Camargo Alves L, Scotini Freitas P, et al. Mental health of women who suffer intimate partner violence during pregnancy. Invest Educ Enferm 2014; 32:291.</a></li><li><a class="nounderline abstract_t">Prober CG. Current antibiotic therapy of community-acquired bacterial infections in hospitalized children: bone and joint infections. Pediatr Infect Dis J 1992; 11:156.</a></li><li><a class="nounderline abstract_t">Shore A, Rush PJ. Possible danger of intra-articular steroid injection in children with respiratory tract infections. Br J Rheumatol 1987; 26:73.</a></li><li><a class="nounderline abstract_t">Raj PP, Shah RV, Kaye AD, et al. Bleeding risk in interventional pain practice: assessment, management, and review of the literature. Pain Physician 2004; 7:3.</a></li><li><a class="nounderline abstract_t">Yui JC, Preskill C, Greenlund LS. Arthrocentesis and Joint Injection in Patients Receiving Direct Oral Anticoagulants. Mayo Clin Proc 2017; 92:1223.</a></li><li><a class="nounderline abstract_t">Tarar MY, Choo XY, Khan S. The Risk of Bleeding Complications in Intra-Articular Injections and Arthrocentesis in Patients on Novel Oral Anticoagulants: A Systematic Review. Cureus 2021; 13:e17755.</a></li><li><a class="nounderline abstract_t">Manners PJ, Price P, Buurman D, et al. Joint Aspiration for Acute Hemarthrosis in Children Receiving Factor VIII Prophylaxis for Severe Hemophilia: 11-year Safety Data. J Rheumatol 2015; 42:885.</a></li><li><a class="nounderline abstract_t">Oren-Ziv A, Hoppenstein D, Shles A, Uziel Y. Sedation methods for intra-articular corticosteroid injections in Juvenile Idiopathic Arthritis: a review. Pediatr Rheumatol Online J 2015; 13:28.</a></li><li><a class="nounderline abstract_t">Cleary AG, Murphy HD, Davidson JE. Intra-articular corticosteroid injections in juvenile idiopathic arthritis. Arch Dis Child 2003; 88:192.</a></li><li><a class="nounderline abstract_t">Harcke HT. Hip in infants and children. Clin Diagn Ultrasound 1995; 30:179.</a></li><li><a class="nounderline abstract_t">Elitsur R, Hollenbeck A, Tasan L, et al. Efficacy and cost savings with the use of a minimal sedation / anxiolysis protocol for intra-articular corticosteroid injections in children with juvenile idiopathic arthritis: a retrospective review of prospectively collected data. Pediatr Rheumatol Online J 2019; 17:11.</a></li><li><a class="nounderline abstract_t">Pascuet E, Donnelly RF, Garceau D, Vaillancourt R. Buffered lidocaine hydrochloride solution with and without epinephrine: stability in polypropylene syringes. Can J Hosp Pharm 2009; 62:375.</a></li><li><a class="nounderline abstract_t">Lunoe MM, Drendel AL, Levas MN, et al. A Randomized Clinical Trial of Jet-Injected Lidocaine to Reduce Venipuncture Pain for Young Children. Ann Emerg Med 2015; 66:466.</a></li><li><a class="nounderline abstract_t">Weiss JE, Uribe AG, Malleson PN, Kimura Y. Anesthesia for intra-articular corticosteroid injections in juvenile idiopathic arthritis: A survey of pediatric rheumatologists. Pediatr Rheumatol Online J 2010; 8:3.</a></li><li><a class="nounderline abstract_t">Uziel Y, Berkovitch M, Gazarian M, et al. Evaluation of eutectic lidocaine/prilocaine cream (EMLA) for steroid joint injection in children with juvenile rheumatoid arthritis: a double blind, randomized, placebo controlled trial. J Rheumatol 2003; 30:594.</a></li><li><a class="nounderline abstract_t">Weiss JE, Haines KA, Chalom EC, et al. A randomized study of local anesthesia for pain control during intra-articular corticosteroid injection in children with arthritis. Pediatr Rheumatol Online J 2015; 13:36.</a></li><li><a class="nounderline abstract_t">Cardone DA, Tallia AF. Joint and soft tissue injection. Am Fam Physician 2002; 66:283.</a></li><li><a class="nounderline abstract_t">Draghi F, Robotti G, Jacob D, Bianchi S. Interventional musculoskeletal ultrasonography: Precautions and contraindications. J Ultrasound 2010; 13:126.</a></li><li><a class="nounderline abstract_t">Zuber TJ. Knee joint aspiration and injection. Am Fam Physician 2002; 66:1497.</a></li><li><a class="nounderline abstract_t">Cardone DA, Tallia AF. Diagnostic and therapeutic injection of the elbow region. Am Fam Physician 2002; 66:2097.</a></li><li><a class="nounderline abstract_t">Tallia AF, Cardone DA. Diagnostic and therapeutic injection of the wrist and hand region. Am Fam Physician 2003; 67:745.</a></li><li><a class="nounderline abstract_t">Tallia AF, Cardone DA. Diagnostic and therapeutic injection of the shoulder region. Am Fam Physician 2003; 67:1271.</a></li><li><a class="nounderline abstract_t">Allen RC, Gross KR, Laxer RM, et al. Intraarticular triamcinolone hexacetonide in the management of chronic arthritis in children. Arthritis Rheum 1986; 29:997.</a></li><li><a class="nounderline abstract_t">Parra DA. Technical tips to perform safe and effective ultrasound guided steroid joint injections in children. Pediatr Rheumatol Online J 2015; 13:2.</a></li><li><a class="nounderline abstract_t">Young CM, Horst DM, Murakami JW, Shiels WE 2nd. Ultrasound-guided corticosteroid injection of the subtalar joint for treatment of juvenile idiopathic arthritis. Pediatr Radiol 2015; 45:1212.</a></li><li><a class="nounderline abstract_t">Arabshahi B, Dewitt EM, Cahill AM, et al. Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis. Arthritis Rheum 2005; 52:3563.</a></li><li><a class="nounderline abstract_t">Jones A, Regan M, Ledingham J, et al. Importance of placement of intra-articular steroid injections. BMJ 1993; 307:1329.</a></li><li><a class="nounderline abstract_t">Weitoft T, Uddenfeldt P. Importance of synovial fluid aspiration when injecting intra-articular corticosteroids. Ann Rheum Dis 2000; 59:233.</a></li><li><a class="nounderline abstract_t">Sibbitt W Jr, Sibbitt RR, Michael AA, et al. Physician control of needle and syringe during aspiration-injection procedures with the new reciprocating syringe. J Rheumatol 2006; 33:771.</a></li><li><a class="nounderline abstract_t">Draeger HT, Twining JM, Johnson CR, et al. A randomised controlled trial of the reciprocating syringe in arthrocentesis. Ann Rheum Dis 2006; 65:1084.</a></li><li><a class="nounderline abstract_t">Zulian F, Martini G, Gobber D, et al. Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology (Oxford) 2004; 43:1288.</a></li><li><a class="nounderline abstract_t">Eberhard BA, Sison MC, Gottlieb BS, Ilowite NT. Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol 2004; 31:2507.</a></li><li><a class="nounderline abstract_t">Eberhard BA, Ilowite NT, Sison C. A dose schedule for intraarticular steroids in juvenile arthritis. J Rheumatol 2012; 39:374.</a></li><li><a class="nounderline abstract_t">Zulian F, Martini G, Gobber D, et al. Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatology (Oxford) 2003; 42:1254.</a></li><li><a class="nounderline abstract_t">Scott C, Meiorin S, Filocamo G, et al. A reappraisal of intra-articular corticosteroid therapy in juvenile idiopathic arthritis. Clin Exp Rheumatol 2010; 28:774.</a></li><li><a class="nounderline abstract_t">Derendorf H, Möllmann H, Grüner A, et al. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther 1986; 39:313.</a></li><li><a class="nounderline abstract_t">Lanni S, Bertamino M, Consolaro A, et al. Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis. Rheumatology (Oxford) 2011; 50:1627.</a></li><li><a class="nounderline abstract_t">Giancane G, Consolaro A, Lanni S, et al. Juvenile Idiopathic Arthritis: Diagnosis and Treatment. Rheumatol Ther 2016; 3:187.</a></li><li><a class="nounderline abstract_t">Jayaram P, Kennedy DJ, Yeh P, Dragoo J. Chondrotoxic Effects of Local Anesthetics on Human Knee Articular Cartilage: A Systematic Review. PM R 2019; 11:379.</a></li><li><a class="nounderline abstract_t">Kreuz PC, Steinwachs M, Angele P. Single-dose local anesthetics exhibit a type-, dose-, and time-dependent chondrotoxic effect on chondrocytes and cartilage: a systematic review of the current literature. Knee Surg Sports Traumatol Arthrosc 2018; 26:819.</a></li><li><a class="nounderline abstract_t">Bliddal H. Intraarticular injection of anti-tumor necrosis factor: Comment on the letter by Arnold et al. Arthritis Rheum 2004; 50:2037.</a></li><li><a class="nounderline abstract_t">Stoll ML, Vaid YN, Guleria S, et al. Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathic Arthritis. J Rheumatol 2015; 42:2155.</a></li><li><a class="nounderline abstract_t">Stoustrup P, Kristensen KD, Verna C, et al. Intra-articular steroid injection for temporomandibular joint arthritis in juvenile idiopathic arthritis: A systematic review on efficacy and safety. Semin Arthritis Rheum 2013; 43:63.</a></li><li><a class="nounderline abstract_t">Vidovic M, Lamot L, Lamot M, Harjacek M. Intraarticular infliximab therapy in patients with juvenile idiopathic arthritis: the role of musculoskeletal ultrasound and disease activity scores in monitoring therapy response. Clin Exp Rheumatol 2018; 36:676.</a></li><li><a class="nounderline abstract_t">Weitoft T, Rönnblom L. Randomised controlled study of postinjection immobilisation after intra-articular glucocorticoid treatment for wrist synovitis. Ann Rheum Dis 2003; 62:1013.</a></li><li><a class="nounderline abstract_t">Wallen M, Gillies D. Intra-articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis. Cochrane Database Syst Rev 2006; :CD002824.</a></li><li><a class="nounderline abstract_t">Peterson C, Hodler J. Adverse events from diagnostic and therapeutic joint injections: a literature review. Skeletal Radiol 2011; 40:5.</a></li><li><a class="nounderline abstract_t">MCCARTY DJ Jr, HOGAN JM. INFLAMMATORY REACTION AFTER INTRASYNOVIAL INJECTION OF MICROCRYSTALLINE ADRENOCORTICOSTEROID ESTERS. Arthritis Rheum 1964; 7:359.</a></li><li><a class="nounderline abstract_t">Hertzberger-ten Cate R, de Vries-van der Vlugt BC, van Suijlekom-Smit LW, Cats A. Intra-articular steroids in pauciarticular juvenile chronic arthritis, type 1. Eur J Pediatr 1991; 150:170.</a></li><li><a class="nounderline abstract_t">Padeh S, Passwell JH. Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 1998; 41:1210.</a></li><li><a class="nounderline abstract_t">Job-Deslandre C, Menkes CJ. Complications of intra-articular injections of triamcinolone hexacetonide in chronic arthritis in children. Clin Exp Rheumatol 1990; 8:413.</a></li><li><a class="nounderline abstract_t">Cassidy JT, Bole GG. Cutaneous atrophy secondary to intra-articular corticosteroid administration. Ann Intern Med 1966; 65:1008.</a></li><li><a class="nounderline abstract_t">Breit W, Frosch M, Meyer U, et al. A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. J Rheumatol 2000; 27:2696.</a></li><li><a class="nounderline abstract_t">Ravelli A, Manzoni SM, Viola S, et al. Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis. J Rheumatol 2001; 28:2100.</a></li><li><a class="nounderline abstract_t">Gilsanz V, Bernstein BH. Joint calcification following intra-articular corticosteroid therapy. Radiology 1984; 151:647.</a></li><li><a class="nounderline abstract_t">Sparling M, Malleson P, Wood B, Petty R. Radiographic followup of joints injected with triamcinolone hexacetonide for the management of childhood arthritis. Arthritis Rheum 1990; 33:821.</a></li><li><a class="nounderline abstract_t">Goldman RD, Benseler SM, Schneider R. Intra-articular calcifications in a child with juvenile rheumatoid arthritis. Arch Dis Child 2005; 90:1038.</a></li><li><a class="nounderline abstract_t">Maugars Y, Albert JD, Bard H, et al. Prevention of iatrogenic infections in interventional rheumatology: Optimal measures but adapted to each risk. Joint Bone Spine 2016; 83:250.</a></li><li><a class="nounderline abstract_t">Huppertz HI, Tschammler A, Horwitz AE, Schwab KO. Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth. J Pediatr 1995; 127:317.</a></li><li><a class="nounderline abstract_t">Earley A, Cuttica RJ, McCullough C, Ansell BM. Triamcinolone into the knee joint in juvenile chronic arthritis. Clin Exp Rheumatol 1988; 6:153.</a></li><li><a class="nounderline abstract_t">Huppertz HI, Pfüller H. Transient suppression of endogenous cortisol production after intraarticular steroid therapy for chronic arthritis in children. J Rheumatol 1997; 24:1833.</a></li><li><a class="nounderline abstract_t">Koehler BE, Urowitz MB, Killinger DW. The systemic effects of intra-articular corticosteroid. J Rheumatol 1974; 1:117.</a></li><li><a class="nounderline abstract_t">Gondwe JS, Davidson JE, Deeley S, et al. Secondary Cushing's syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration. Rheumatology (Oxford) 2005; 44:1457.</a></li><li><a class="nounderline abstract_t">Habib GS. Systemic effects of intra-articular corticosteroids. Clin Rheumatol 2009; 28:749.</a></li><li><a class="nounderline abstract_t">Goldzweig O, Carrasco R, Hashkes PJ. Systemic adverse events following intraarticular corticosteroid injections for the treatment of juvenile idiopathic arthritis: two patients with dermatologic adverse events and review of the literature. Semin Arthritis Rheum 2013; 43:71.</a></li><li><a class="nounderline abstract_t">Kumar S, Singh RJ, Reed AM, Lteif AN. Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients. Pediatrics 2004; 113:1820.</a></li><li><a class="nounderline abstract_t">Balogh Z, Ruzsonyi E. Triamcinolone hexacetonide versus betamethasone. A double-blind comparative study of the long-term effects of intra-articular steroids in patients with juvenile chronic arthritis. Scand J Rheumatol Suppl 1987; 67:80.</a></li></ol></div><div id="topicVersionRevision">Topic 6425 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Faryna A, Goldenberg K. Joint fluid. In: Clinical Methods: The History, Physical, and Laboratory Examinations, 3rd ed, Walker HK, Hall WD, Hurst JW (Eds), Butterworths, Boston 1990.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30036290" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Gram Stain is Not Clinically Relevant in Treatment of Pediatric Septic Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28366221" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Septic Arthritis of Native Joints.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24959104" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The clinical effectiveness of intra-articular corticosteroids for arthritis of the lower limb in juvenile idiopathic arthritis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23335483" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17118212" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Arthritis and pain. Neurogenic origin of joint pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31765551" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Emergency department management of pediatric septic arthritis and osteomyelitis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15105721" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Treatment of septic arthritis of the hip joint by repeated ultrasound-guided aspirations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15448390" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Management of septic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14819944" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Practical considerations of the use of cortisone and ACTH in rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14880415" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hydrocortisone and cortisone injected into arthritic joints; comparative effects of and use of hydrocortisone as a local antiarthritic agent.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25230039" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Mental health of women who suffer intimate partner violence during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1741195" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Current antibiotic therapy of community-acquired bacterial infections in hospitalized children: bone and joint infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3814981" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Possible danger of intra-articular steroid injection in children with respiratory tract infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16868610" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Bleeding risk in interventional pain practice: assessment, management, and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28778256" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Arthrocentesis and Joint Injection in Patients Receiving Direct Oral Anticoagulants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34659968" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The Risk of Bleeding Complications in Intra-Articular Injections and Arthrocentesis in Patients on Novel Oral Anticoagulants: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25729030" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Joint Aspiration for Acute Hemarthrosis in Children Receiving Factor VIII Prophylaxis for Severe Hemophilia: 11-year Safety Data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26141717" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Sedation methods for intra-articular corticosteroid injections in Juvenile Idiopathic Arthritis: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12598375" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Intra-articular corticosteroid injections in juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7756025" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Hip in infants and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30894194" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Efficacy and cost savings with the use of a minimal sedation / anxiolysis protocol for intra-articular corticosteroid injections in children with juvenile idiopathic arthritis: a retrospective review of prospectively collected data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22478919" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Buffered lidocaine hydrochloride solution with and without epinephrine: stability in polypropylene syringes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25935844" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : A Randomized Clinical Trial of Jet-Injected Lidocaine to Reduce Venipuncture Pain for Young Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20142994" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Anesthesia for intra-articular corticosteroid injections in juvenile idiopathic arthritis: A survey of pediatric rheumatologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12610822" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Evaluation of eutectic lidocaine/prilocaine cream (EMLA) for steroid joint injection in children with juvenile rheumatoid arthritis: a double blind, randomized, placebo controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26310855" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A randomized study of local anesthesia for pain control during intra-articular corticosteroid injection in children with arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12152964" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Joint and soft tissue injection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23396633" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Interventional musculoskeletal ultrasonography: Precautions and contraindications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12408424" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Knee joint aspiration and injection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12484691" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Diagnostic and therapeutic injection of the elbow region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12613728" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Diagnostic and therapeutic injection of the wrist and hand region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12674455" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Diagnostic and therapeutic injection of the shoulder region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3741522" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Intraarticular triamcinolone hexacetonide in the management of chronic arthritis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25745367" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Technical tips to perform safe and effective ultrasound guided steroid joint injections in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25672519" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Ultrasound-guided corticosteroid injection of the subtalar joint for treatment of juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16255045" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8257889" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Importance of placement of intra-articular steroid injections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10700435" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Importance of synovial fluid aspiration when injecting intra-articular corticosteroids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16511940" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Physician control of needle and syringe during aspiration-injection procedures with the new reciprocating syringe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16339287" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A randomised controlled trial of the reciprocating syringe in arthrocentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15252213" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15570659" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22133622" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : A dose schedule for intraarticular steroids in juvenile arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12810938" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20863449" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A reappraisal of intra-articular corticosteroid therapy in juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3948470" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21561981" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27747582" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Juvenile Idiopathic Arthritis: Diagnosis and Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30676699" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Chondrotoxic Effects of Local Anesthetics on Human Knee Articular Cartilage: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28289821" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Single-dose local anesthetics exhibit a type-, dose-, and time-dependent chondrotoxic effect on chondrocytes and cartilage: a systematic review of the current literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15188385" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Intraarticular injection of anti-tumor necrosis factor: Comment on the letter by Arnold et al.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26329345" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathic Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23352251" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Intra-articular steroid injection for temporomandibular joint arthritis in juvenile idiopathic arthritis: A systematic review on efficacy and safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29600948" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Intraarticular infliximab therapy in patients with juvenile idiopathic arthritis: the role of musculoskeletal ultrasound and disease activity scores in monitoring therapy response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12972485" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Randomised controlled study of postinjection immobilisation after intra-articular glucocorticoid treatment for wrist synovitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16437446" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Intra-articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19949787" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Adverse events from diagnostic and therapeutic joint injections: a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14202574" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : INFLAMMATORY REACTION AFTER INTRASYNOVIAL INJECTION OF MICROCRYSTALLINE ADRENOCORTICOSTEROID ESTERS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2044586" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Intra-articular steroids in pauciarticular juvenile chronic arthritis, type 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9663477" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Intraarticular corticosteroid injection in the management of children with chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2397629" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Complications of intra-articular injections of triamcinolone hexacetonide in chronic arthritis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4224245" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Cutaneous atrophy secondary to intra-articular corticosteroid administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11093456" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11550981" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6718724" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Joint calcification following intra-articular corticosteroid therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2363737" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Radiographic followup of joints injected with triamcinolone hexacetonide for the management of childhood arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16177158" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Intra-articular calcifications in a child with juvenile rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26494595" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Prevention of iatrogenic infections in interventional rheumatology: Optimal measures but adapted to each risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7636665" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3180542" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Triamcinolone into the knee joint in juvenile chronic arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9292813" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Transient suppression of endogenous cortisol production after intraarticular steroid therapy for chronic arthritis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4459468" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The systemic effects of intra-articular corticosteroid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16244103" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Secondary Cushing's syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19252817" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Systemic effects of intra-articular corticosteroids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23332901" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Systemic adverse events following intraarticular corticosteroid injections for the treatment of juvenile idiopathic arthritis: two patients with dermatologic adverse events and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15173517" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3330864" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Triamcinolone hexacetonide versus betamethasone. A double-blind comparative study of the long-term effects of intra-articular steroids in patients with juvenile chronic arthritis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
